Medline and Jiangsu Shenli Medical Production Co. have initiated recalls of plastic syringes amid reports of them breaking and leaking, the FDA confirmed in late May. The two companies have recalled ...

The U.S. Food and Drug Administration has issued a safety notice to consumers, health care providers and facilities that it is evaluating plastic syringes made in China for potential device failures.

Lest this week’s news about FDA cautioning against the use of plastic syringes made in China raise concerns of a possible shortage, BD announced today that it is increasing its US production of ...

The FDA last week re-upped its recommendations that healthcare providers avoid using plastic syringes made in China wherever possible, while it continues to investigate growing quality concerns. In ...

FDA recently announced an update to its safety communication recommending that US suppliers immediately transition away from using plastic syringes manufactured by specific China-based companies. In ...

Nearly six months after the FDA told healthcare workers to avoid plastic syringes made in China, the agency has placed import alerts on three China-based medical supply manufacturers. In late November ...

The U.S. Food and Drug Administration has issued import warnings against more plastic syringes manufactured in China. On May 16, FDA issued an updated safety alert urging health care providers to stop ...

FDA has updated its recommendation for healthcare providers concerning not using plastic syringes made in China to include an import alert for Zhejiang Longde Pharmaceutical Co. Ltd. and Shandhai ...

The FDA is advising U.S. healthcare providers and patients to stop using any plastic syringes in their inventories that were made in China, if possible, as it looks into a spate of quality complaints.

(Reuters) -The U.S. Food and Drug Administration said on Friday that Merit Medical Systems has initiated a recall for unapproved plastic syringes supplied by China-based Jiangsu Shenli Medical ...

BD has turned to Mitsubishi Gas Chemical (MGC) to look into ways to improve the delivery of biologics, signing a letter of intent that positions it to assess its partner’s alternative to glass for ...